Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    

Global Drug formulations Market Research Report

PRODUCT TITLE PUBLISHED
Antigrowth hormones Antigrowth hormones
Antigrowth hormones and its peer markets - E-Clinical Trial Solutions,
Upcoming
Anti-gonadotropin-releasing hormones Anti-gonadotropin-releasing hormones
Anti-gonadotropin-releasing hormones and its peer markets - Chromatography,
Upcoming
Mineralocorticoids Mineralocorticoids
Mineralocorticoids and its peer markets - Chromatography Instruments,
Upcoming
Glucocorticoids Glucocorticoids
Glucocorticoids and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Anticorticosteroids Anticorticosteroids
Anticorticosteroids and Chromatography, E-Clinical Trial...
Upcoming
Thiouracils Thiouracils
Thiouracils and its peer markets - Healthcare IT outsourcing,
Upcoming
Sulfur-containing imidazole derivatives Sulfur-containing imidazole derivatives
Sulfur-containing imidazole derivatives and its peer markets - Proteomics,
Upcoming
Perchlorates Perchlorates
Perchlorates and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Calcitonin preparations Calcitonin preparations
Calcitonin preparations and its peer markets - E-Clinical Trial Solutions,
Upcoming
Antimycobacterial Aminosalicylic acid and derivatives Antimycobacterial Aminosalicylic acid and derivatives
Antimycobacterial Aminosalicylic acid and derivatives and its peer markets - E-Clinical Trial Solutions,
Upcoming
Antimycobacterial Antibiotics Antimycobacterial Antibiotics
Antimycobacterial Antibiotics and its peer markets - Combinations of drugs for treatment of tuberculosis, E-Clinical Trial Solutions,
Upcoming
Antimycobacterial Hydrazides Antimycobacterial Hydrazides
Antimycobacterial Hydrazides and its peer markets - Proteomics,
Upcoming
Antimycobacterial Thiocarbamide derivatives Antimycobacterial Thiocarbamide derivatives
Antimycobacterial Thiocarbamide derivatives and its peer markets - E-Clinical Trial Solutions,
Upcoming
Testosterone-5-alpha reductase inhibitors Testosterone-5-alpha reductase inhibitors
Testosterone-5-alpha reductase inhibitors and its peer markets - Digital Pathology,
Upcoming
Nivolumab Nivolumab
Nivolumab and Chromatography, E-Clinical Trial...
Upcoming
Hyper-CVAD regimen Hyper-CVAD regimen
Hyper-CVAD regimen and CALGB 8811 regimen, Linker Regimen,
Upcoming
CALGB 8811 regimen CALGB 8811 regimen
CALGB 8811 regimen and Hyper-CVAD regimen, Linker Regimen,
Upcoming
Linker Regimen Linker Regimen
Linker Regimen and Hyper-CVAD regimen, CALGB 8811 regimen,...
Upcoming
Nucleoside Metabolic Inhibitors (Clolar + Nelarabine) Nucleoside Metabolic Inhibitors (Clolar + Nelarabine)
Nucleoside Metabolic Inhibitors (Clolar + Nelarabine) and Hyper-CVAD regimen,
Upcoming
Oncaspar (Pegaspargase) Oncaspar (Pegaspargase)
Oncaspar (Pegaspargase) and Hyper-CVAD regimen, CALGB 8811...
Upcoming
693 reports | Show
Connect With Us
US/CAN : +1-888-502-0539